BOTHELL, Wash.--(BUSINESS WIRE)--Sonus Pharmaceuticals, Inc. (NASDAQ: SNUS), an oncology drug development company, today announced that Michael A. Martino, President and CEO, will participate in two investor conferences in June 2007: Bear Stearns Boston Biotech Confab, June 7; and the Needham & Company Biotechnology & Medical Technology Conference, being held June 13-14.
